Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Single-Cell Analysis of Neoplastic Plasma Cells Identifies Myeloma Pathobiology Mediators and Potential Targets, Luz Yurany Moreno Rueda, Hua Wang, Keiko Akagi, et al.
Structural Insights Into Light-Gating of Potassium-Selective Channelrhodopsin, Takefumi Morizumi, Kyumhyuk Kim, Hai Li, et al.
DNA Damage Response Signatures Are Associated With Frontline Chemotherapy Response and Routes of Tumor Evolution in Extensive Stage Small Cell Lung Cancer, Benjamin B Morris, Simon Heeke, Yuanxin Xi, et al.
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal, Van K Morris, Suyu Liu, Kangyu Lin, et al.
Phase 1/2 Trial of Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E Metastatic Colorectal Cancer, Van K Morris, Christine M Parseghian, Vahid Bahrambeigi, et al.
Phase 1/2 Trial of Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E Metastatic Colorectal Cancer, Van K Morris, Christine M Parseghian, Vahid Bahrambeigi, et al.
Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer, Van K Morris, Weihong Xiao, Kangyu Lin, et al.
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Metastatic Variant Histology (Non-Clear Cell) Renal Cell Carcinoma, Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract, Mohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke, et al.
Sitravatinib in Combination With Nivolumab Plus Ipilimumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: A Phase 1 Trial, Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Risk Factors and Clinical Significance of Urologic Injury in Cesarean Hysterectomy for Placenta Accreta Spectrum, J Connor Mulhall, Kayla E Ireland, John J Byrne, et al.
SARS-CoV-2 RNA-Binding Protein Suppresses Extracellular miRNA Release, Hyejin Mun, Chang Hoon Shin, Qingxuan Fei, et al.
Trametinib Decreased Intracerebral Hemorrhages and Endothelial-to-Mesenchymal Transition in KRAS, Ohnmar Myint, Bridger Freeman, Jae Yeong Jeong, et al.
Diet and Survival After a Diagnosis of Ovarian Cancer: A Pooled Analysis From the Ovarian Cancer Association Consortium, Christina M Nagle, Torukiri I Ibiebele, Renhua Na, et al.
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study, Aung Naing, Amit Mahipal, Milind Javle, et al.
TIGIT Inhibitor M6223 As Monotherapy or in Combination With Bintrafusp Alfa in Patients With Advanced Solid Tumors: A First-in-Human, Phase 1, Dose-Escalation Trial, Aung Naing, Meredith McKean, Anthony Tolcher, et al.
Generation of Human Induced Pluripotent Stem Cell Line From a Familial Alzheimer’s Disease Patient Carrying Missense Mutations in PSEN1 and MAPT Genes, Ashaq H Najar, Sofia E Sepulveda, Camila Gherardelli, et al.
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial, Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen, et al.
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial, Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Natural History Models for Lung Cancer: A Scoping Review, Renu Sara Nargund, Sayaka Ishizawa, Maryam Eghbalizarch, et al.
Childhood Trauma and Inflammatory Biomarker Effects on Cortical Thinning in Schizophrenia Spectrum Disorders, Samantha Narvaez, Yizhou Ma, Joshua Chiappelli, et al.
First-Line PD-1 +/- CTLA-4 Blockade in Patients With Deficient Mismatch Repair and/or Microsatellite Instability-High Metastatic Colorectal Cancer, Vincenzo Nasca, Gabriele Tinè, Julien Taieb, et al.
Sex and Outcomes of Patients With Microsatellite Instability-High and Braf V600E Mutated Metastatic Colorectal Cancer Receiving Immune Checkpoint Inhibitors, Vincenzo Nasca, Joseph Zhao, Javier Ros, et al.
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma, Loretta J Nastoupil, Clark R Andersen, Amy Ayers, et al.
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial, Marcelo V Negrao, Alvaro G Paula, David Molkentine, et al.